These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9362439)

  • 1. Ibandronate in oncology.
    Burckhardt P
    Cancer; 1997 Oct; 80(8 Suppl):1696-8. PubMed ID: 9362439
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibandronate.
    Dooley M; Balfour JA
    Drugs; 1999 Jan; 57(1):101-8; discussion 109-10. PubMed ID: 9951955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic agents for disorders of bone and calcium metabolism: Zoledronic acid].
    Sakurai T
    Clin Calcium; 2007 Jan; 17(1):24-8. PubMed ID: 17211090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
    Guay DR
    Pharmacotherapy; 2006 May; 26(5):655-73. PubMed ID: 16637795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
    Wang T; Song ST; Jiang ZF; Bian SG; Wang YJ; Li LQ; Zhu J
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):739-41. PubMed ID: 15733393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of using Aredia for hypercalcemia in oncology patients].
    Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV
    Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ibandronate].
    Yamada T; Suzuki M; Kuwahara T; Tanaka Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():536-9. PubMed ID: 15035186
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of bisphosphonates in cancer patients.
    Body JJ; Coleman RE; Piccart M
    Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
    [No Abstract]   [Full Text] [Related]  

  • 9. Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
    Heidenreich A; Ohlmann CH
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):991-1005. PubMed ID: 15606328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344758
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biphosphonate therapy in the management of skeletal metastases].
    Grauer A; Ziegler R
    Orthopade; 1998 Apr; 27(4):231-9. PubMed ID: 9616882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral diphosphonates for treating malignant hypercalcemia.
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
    Pecherstorfer M; Herrmann Z; Body JJ; Manegold C; Degardin M; Clemens MR; Thürlimann B; Tubiana-Hulin M; Steinhauer EU; van Eijkeren M; Huss HJ; Thiébaud D
    J Clin Oncol; 1996 Jan; 14(1):268-76. PubMed ID: 8558208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous ibandronate (Boniva).
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):68-9. PubMed ID: 16977282
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates for metastatic bone pain.
    Body JJ
    Support Care Cancer; 1999 Jan; 7(1):1-3. PubMed ID: 9926966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of the new bisphosphonate ibandronate in the management of bone metastasis following rapid infusion.
    Syrigos KN; Michalaki V; Mitromaras A; Pliarchopoulou F; Katirtzoglou N; Antonaki E; Roussou P
    In Vivo; 2002; 16(5):361-3. PubMed ID: 12494878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
    Westermann AM
    Ann Oncol; 2004 Mar; 15(3):537-8. PubMed ID: 14998861
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates and reduction of skeletal events in patients with bone metastatic breast cancer.
    Rizzoli R
    Ann Oncol; 2004 May; 15(5):700-1. PubMed ID: 15111335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.